Drugs that contain Selegiline Hydrochloride
1. Zelapar patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5648093 | BAUSCH | Pharmaceutical and other dosage forms |
Jul, 2014
(9 years ago) | |
| US6423342 | BAUSCH | Process for the preparation of a solid pharmaceutical dosage form |
Mar, 2016
(8 years ago) | |
Market Authorisation Date: 14 June, 2006
Treatment: NA
Dosage: TABLET, ORALLY DISINTEGRATING;ORAL
More Information on Dosage
ZELAPAR family patents
